We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LKFT
1476
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $405K | ﹤0.01% |
1,959
+1,644
| +522% | +$304K |
|
1477
MidCap Financial Investment
MFIC
$784M
| $405K | ﹤0.01% |
23,240
+20,400
| +718% | +$336K |
|
|
XFLT
1478
XAI Floating Rate & Alternative Income Trust
XFLT
$268M
| $405K | ﹤0.01% |
10,000
| – | – |
|
|
GTLS
1479
DELISTED
Chart Industries
GTLS
| $403K | ﹤0.01% |
5,974
+2,655
| +80% | +$155K |
|
1480
Simmons First National
SFNC
$3.35B
| $399K | ﹤0.01% |
14,910
+14,701
| +7,034% | +$371K |
|
1481
Astec Industries
ASTE
$1.3B
| $397K | ﹤0.01% |
9,439
-30,927
| -77% | -$1.12M |
|
1482
La-Z-Boy
LZB
$1.59B
| $394K | ﹤0.01% |
12,526
+3,558
| +40% | +$119K |
|
1483
Murphy USA
MUSA
$11.3B
| $392K | ﹤0.01% |
3,352
-115
| -3% | -$12.4K |
|
1484
BJ's Restaurants
BJRI
$1.41B
| $391K | ﹤0.01% |
10,315
-2,361
| -19% | -$90.5K |
|
1485
Interparfums
IPAR
$3.92B
| $391K | ﹤0.01% |
5,382
+1,552
| +41% | +$113K |
|
1486
AGNC Investment
AGNC
$12.3B
| $389K | ﹤0.01% |
22,017
-8,100
| -27% | -$138K |
|
1487
Dawson Geophysical
DWSN
$155M
| $389K | ﹤0.01% |
161,898
-28,245
| -15% | -$65.8K |
|
1488
UGI
UGI
$8B
| $388K | ﹤0.01% |
8,600
+356
| +4% | +$16.3K |
|
1489
Invesco S&P SmallCap Low Volatility ETF
XSLV
$249M
| $388K | ﹤0.01% |
7,619
+2,585
| +51% | +$129K |
|
1490
Alerus Financial
ALRS
$822M
| $387K | ﹤0.01% |
16,955
| – | – |
|
1491
Chesapeake Utilities
CPK
$3.26B
| $385K | ﹤0.01% |
4,019
+1,459
| +57% | +$136K |
|
1492
Phibro Animal Health
PAHC
$1.38B
| $385K | ﹤0.01% |
15,481
+3,878
| +33% | +$90K |
|
1493
Ericsson
ERIC
$30.7B
| $384K | ﹤0.01% |
43,575
-53,490
| -55% | -$473K |
|
1494
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.38B
| $384K | ﹤0.01% |
19,370
-300
| -2% | -$5.63K |
|
|
SHYF
1495
DELISTED
The Shyft Group
SHYF
| $384K | ﹤0.01% |
21,232
-2,968
| -12% | -$49.6K |
|
1496
Empire State Realty Trust
ESRT
$976M
| $383K | ﹤0.01% |
27,427
+4,135
| +18% | +$58.1K |
|
1497
iShares Dow Jones US ETF
IYY
$2.92B
| $383K | ﹤0.01% |
4,804
-18
| -0.4% | -$1.38K |
|
1498
Vanguard FTSE Pacific ETF
VPL
$8.05B
| $382K | ﹤0.01% |
5,501
-128
| -2% | -$8.78K |
|
1499
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
| $381K | ﹤0.01% |
5,359
-226
| -4% | -$15.2K |
|
1500
ENI
E
$76B
| $381K | ﹤0.01% |
12,266
-2,003
| -14% | -$61.3K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.